Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2017
Reporting Period: Quarterly period ended September 30, 2017
Status: Emerging Growth Company
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding financial results. The filing text itself does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1), which is furnished but not filed within this document.
Material Changes
The filing does not provide specific details on material changes versus the prior comparable period. It references the attached press release for the announcement of results for the quarter ended September 30, 2017.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. Such information is contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2017) for specific revenue, net loss, and cash position figures.
- Verify the company's status as an Emerging Growth Company and any associated accounting election implications.
- Confirm the details of the quarterly results for the period ended September 30, 2017, as the 8-K only references the announcement.